2-96265165-C-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_017849.4(TMEM127):​c.217G>C​(p.Gly73Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000863 in 1,611,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G73D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000092 ( 0 hom. )

Consequence

TMEM127
NM_017849.4 missense

Scores

5
9
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:7B:1

Conservation

PhyloP100: 7.12

Publications

3 publications found
Variant links:
Genes affected
TMEM127 (HGNC:26038): (transmembrane protein 127) This gene encodes a transmembrane protein with four predicted transmembrane domains. The protein is associated with a subpopulation of vesicular organelles corresponding to early endosomal structures, with the Golgi, and with lysosomes, and may participate in protein trafficking between these structures. Mutations in this gene and several other genes cause pheochromocytomas. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2022]
TMEM127 Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.849
BS2
High AC in GnomAd4 at 5 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017849.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMEM127
NM_017849.4
MANE Select
c.217G>Cp.Gly73Arg
missense
Exon 2 of 4NP_060319.1
TMEM127
NM_001193304.3
c.217G>Cp.Gly73Arg
missense
Exon 2 of 4NP_001180233.1
TMEM127
NM_001407283.1
c.-9+704G>C
intron
N/ANP_001394212.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TMEM127
ENST00000258439.8
TSL:1 MANE Select
c.217G>Cp.Gly73Arg
missense
Exon 2 of 4ENSP00000258439.3
TMEM127
ENST00000432959.2
TSL:1
c.217G>Cp.Gly73Arg
missense
Exon 2 of 4ENSP00000416660.1
TMEM127
ENST00000713754.1
n.217G>C
non_coding_transcript_exon
Exon 2 of 4ENSP00000519055.1

Frequencies

GnomAD3 genomes
AF:
0.0000328
AC:
5
AN:
152262
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000372
AC:
9
AN:
241688
AF XY:
0.0000303
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000832
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000918
AC:
134
AN:
1459172
Hom.:
0
Cov.:
31
AF XY:
0.0000758
AC XY:
55
AN XY:
725764
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33460
American (AMR)
AF:
0.00
AC:
0
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26100
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85860
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51856
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000116
AC:
129
AN:
1111546
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
10
21
31
42
52
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152262
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5208
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000264
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000578
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:7Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pheochromocytoma Pathogenic:1Uncertain:3Benign:1
Jul 12, 2023
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Familial Cancer Clinic, Veneto Institute of Oncology
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Mar 07, 2024
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The TMEM127 c.217G>C (p.Gly73Arg) missense change has a maximum subpopulation frequency of 0.008% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org). The in silico tool REVEL is inconclusive about a pathogenic or benign effect of this variant on protein function. This variant has been reported in an individual with pheochromocytoma (PMID: 22136840). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance.

Jun 01, 2014
CSER _CC_NCGL, University of Washington
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:research

Jan 01, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:2
May 10, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The frequency of this variant in the general population, 0.000081 (10/123534 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. In the published literature, the variant has been reported in an individual with pheochromocytoma (PMID: 21156949 (2010)). A published functional study has reported that this variant does not have a deleterious effect on TMEM127 protein localization and expression (PMID: 32575117 (2020)), however additional studies are required to determine the global effect of this variant on TMEM127 protein function. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant.

May 14, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed in an individual with pheochromocytoma (PMID: 21156949); Published functional studies demonstrate no damaging effect: cellular localization and protein expression levels similar to wildtype (PMID: 32575117); In silico analysis suggests that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25637381, 32575117, 33051659, 21156949, 22136840, 37937776)

Hereditary cancer-predisposing syndrome Uncertain:1
Oct 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G73R variant (also known as c.217G>C), located in coding exon 1 of the TMEM127 gene, results from a G to C substitution at nucleotide position 217. The glycine at codon 73 is replaced by arginine, an amino acid with dissimilar properties. This variant has been detected in an Italian male with an apparently sporadic adrenal paraganglioma diagnosed at age 44 (Yao L et al, JAMA 2010 Dec; 304(23):2611-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.

Hereditary pheochromocytoma-paraganglioma Uncertain:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 73 of the TMEM127 protein (p.Gly73Arg). This variant is present in population databases (rs121908820, gnomAD 0.008%). This missense change has been observed in individual(s) with pheochromocytoma (PMID: 21156949). ClinVar contains an entry for this variant (Variation ID: 126965). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect TMEM127 function (PMID: 32575117). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.31
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.057
T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.46
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D
M_CAP
Uncertain
0.29
D
MetaRNN
Pathogenic
0.85
D
MetaSVM
Uncertain
-0.089
T
MutationAssessor
Benign
1.5
L
PhyloP100
7.1
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.9
N
REVEL
Uncertain
0.63
Sift
Uncertain
0.0070
D
Sift4G
Benign
0.10
T
Polyphen
1.0
D
Vest4
0.94
MVP
0.79
MPC
1.2
ClinPred
0.37
T
GERP RS
4.6
Varity_R
0.36
gMVP
0.94
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908820; hg19: chr2-96930903; API